HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kapiotis Selected Research

Therapeutics

11/2014Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
9/2003Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kapiotis Research Topics

Disease

6Atherosclerosis
06/2014 - 01/2000
5Inflammation (Inflammations)
08/2008 - 05/2000
3Thrombosis (Thrombus)
11/2014 - 03/2000
2Atrial Fibrillation
11/2014 - 06/2011
2Acute Coronary Syndrome
11/2014 - 12/2001
2Type 2 Diabetes Mellitus (MODY)
11/2008 - 01/2007
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2020
1Hyperuricemia
05/2020
1Chronic Renal Insufficiency
06/2014
1Stroke (Strokes)
06/2011
1Venous Thromboembolism
06/2011
1Endotoxemia
08/2008
1Renal Insufficiency (Renal Failure)
01/2007
1Albuminuria
01/2007
1Necrosis
12/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2006
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2001
1Neoplasm Metastasis (Metastasis)
03/2001
1Diabetes Complications
01/2001
1Vascular Diseases (Vascular Disease)
01/2001
1Hemorrhage
08/2000
1Postoperative Hemorrhage
08/2000
1Leukemia
04/2000
1Critical Illness (Critically Ill)
03/2000
1Rheumatoid Arthritis
01/2000
1Osteoarthritis
01/2000

Drug/Important Bio-Agent (IBA)

4oxidized low density lipoproteinIBA
06/2014 - 03/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2006 - 02/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2003 - 03/2001
2LDL Lipoproteins (beta Lipoproteins)IBA
02/2001 - 03/2000
2Glucose (Dextrose)FDA LinkGeneric
01/2001 - 03/2000
2ProstaglandinsIBA
08/2000 - 05/2000
1Uric Acid (Urate)IBA
05/2020
1Uremic ToxinsIBA
06/2014
1Factor Xa (Coagulation Factor Xa)IBA
06/2011
1edoxabanIBA
06/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2008
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2008
1Angiotensin Receptor AntagonistsIBA
11/2008
1Pioglitazone (Actos)FDA Link
08/2008
1EndotoxinsIBA
08/2008
1CytokinesIBA
08/2008
1dimethylarginineIBA
01/2007
1Nitric Oxide Synthase (NO Synthase)IBA
01/2007
1Interleukin-10 (Interleukin 10)IBA
12/2006
1Interleukin-6 (Interleukin 6)IBA
12/2006
1InterleukinsIBA
12/2006
1Insulin (Novolin)FDA Link
08/2006
1Nicotinamide PhosphoribosyltransferaseIBA
08/2006
1AdipokinesIBA
08/2006
1Escherichia coli endotoxinIBA
09/2003
1LipopolysaccharidesIBA
09/2003
1NucleotidesIBA
12/2001
15' Untranslated Regions (5' UTR)IBA
12/2001
1Factor XII (Hageman Factor)IBA
12/2001
1AntibodiesIBA
04/2001
1ErythropoietinFDA Link
04/2001
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2001
1NF-KappaB Inhibitor alphaIBA
02/2001
1NF-kappa B (NF-kB)IBA
02/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
02/2001
1GenisteinIBA
01/2001
1Advanced Glycation End ProductsIBA
01/2001
1Alprostadil (Muse)FDA LinkGeneric
08/2000
1HLA-DR Antigens (HLA-DR)IBA
04/2000
1AntigensIBA
04/2000
1Heparin (Liquaemin)FDA LinkGeneric
03/2000
1Stem Cell FactorIBA
01/2000
1von Willebrand FactorIBA
01/2000

Therapy/Procedure

2Therapeutics
11/2014 - 09/2003
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2000
1Catheters
03/2000